Priscilla Zawislak, Chair, IPEC-Americas
This presentation from the USP Excipient Stakeholder Forum covers the industry’s perspective on atypical actives, including definitions, regulatory and compendial concerns, GMPs, supply chain issues and risk management. Challenges, opportunities and proposed next steps are discussed.
Subject area:
Excipients
Objectives (If applicable):
n/a
Target Audience (If applicable):